Vascular endothelial growth factor gene polymorphisms and serum levels in Behçet's disease

Tissue Antigens

Volumn 72, Issue 6, 2008, Pages 581-587

  Kamoun, M ^a   Houman, M H ^b   Hamzaoui, A ^a,b,c   Hamzaoui, K ^a,d  

^a UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^b LA RABTA HOSPITAL   (Tunisia)

^c ABDERRAHMAN MAMI HOSPITAL   (Tunisia)

^d UNIVERSITY OF TUNIS   (Tunisia)

Author keywords

Beh et's disease; Ocular inflammation; Polymorphisms; Severity; Vascular endothelial growth factor

Indexed keywords

RESTRICTION ENDONUCLEASE; VASCULOTROPIN;

ADULT; ARTICLE; BEHCET DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE INFLAMMATION; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; TUNISIA; VASCULOTROPIN BLOOD LEVEL;

ADULT; BEHCET SYNDROME; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TUNISIA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 55949125070     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2008.01145.x     Document Type: Article

References (47)

1. Yazici H, Yurdakul S, Hamuryudan V. Behcet disease. Curr Opin Rheumatol 2001 : 13 : 18 22.
2. Kaklamani VG, Vaiopoulos G, Kaklamanis PG. Behcet's disease. Semin Arthritis Rheum 1998 : 27 : 197 217.
3. Sakane T, Takeno M, Suzuki N, Inaba G. Behcet's disease. N Engl J Med 1999 : 341 : 1284 91.
4. Gul A, Hajeer AH, Worthington J, Barrett JH, Ollier WE, Silman AJ. Evidence for linkage of the HLA-B locus in Behcet's disease obtained using the transmission disequilibrium test. Arthritis Rheum 2001 : 44 : 239 40.
5. Marshall SE. Behçet's disease. Best Pract Res Clin Rheumatol 2004 : 18 : 291 311.
6. Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR. Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 1999 : 54 : 213 20.
7. Önder M, Gürer MA. The multiple faces of Behçet's disease and its aetiological factors. J Eur Acad Dermatol Venereol 2001 : 15 : 126 36.
8. Kone-Paut I, Geisler I, Wechsler B et al. Familial aggregation in Behcet's disease high frequency in siblings and parents of pediatric probands. J Pediatr 1999 : 135 : 89 93.
9. Fresko I, Soy M, Hamuryudan V et al. Genetic anticipation in Behcet's syndrome. Ann Rheum Dis 1998 : 57 : 45 8.
10. Arayssi T, Hamdan A. New insights into the pathogenesis and therapy of Behçet's disease. Curr Opin Pharmacol 2004 : 4 : 183 8.
11. Mizuki N, Inoko H, Ohno S. Molecular genetics (HLA) of Behçet's disease. Yonsei Med J 1997 : 38 : 333 49.
12. Ota M, Mizuki N, Katsuyama Y et al. The critical region for Behçet disease in the human major histocompatibility complex is reduced to a 46-kb segment centromeric of HLA-B, by association analysis using refined microsatellite mapping. Am J Hum Genet 1999 : 64 : 1406 10.
13. Verity DH, Wallace GR, Vaughan RW, Stanford MR. Behcet's disease from Hippocrates to the third millennium. Br J Ophthalmol 2003 : 87 : 1175 83.
14. Nam EJ, Han SW, Kim SU et al. Association of vascular endothelial growth factor gene polymorphisms with behcet disease in a Korean population. Hum Immunol 2005 : 66 : 1068 73.
15. Keyt B, Berleau L, Nguyen H et al. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem 1996 : 271 : 7788 7795.
16. Paroli MP, Teodori C, D'Alessandro M, Mariani P, Iannucci G, Paroli M. Increased vascular endothelial growth factor levels in aqueous humor and serum of patients with quiescent uveitis. Eur J Ophthalmol 2007 : 17 : 938 42.
17. Yalçin B, Arda N, Tezel GG, Erman M, Alli N. Expressions of vascular endothelial growth factor and CD34 in oral aphthous lesions of Behçet's disease. Anal Quant Cytol Histol 2006 : 28 : 303 6.
18. Shaker O, Ay El-Deen MA, El Hadidi H, Grace BD, El Sherif H, Abdel Halim A. The role of heat shock protein 60, vascular endothelial growth factor and antiphospholipid antibodies in Behçet disease. Br J Dermatol 2007 : 156 : 32 7.
19. Bozoglu E, Dinc A, Erdem H, Pay S, Simsek I, Kocar IH. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis. Clin Exp Rheumatol 2005 : 23 : 42 8.
20. Cekmen M, Evereklioglu C, Er H et al. Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome. Int J Dermatol 2003 : 42 : 870 5.
21. Mor F, Quintana FJ, Cohen IR. Angiogenesis-inflammation cross-talk vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J Immunol 2004 : 172 : 4618 23.
22. Frassanito MA, Dammacco R, Cafforio P, Dammacco F. Th1 polarization of the immune response in Behcet's disease a putative pathogenetic role of interleukin-12. Arthritis Rheum 1999 : 42 : 1967 74.
23. Rothenberg ME. VEGF obstructs the lungs. Nat Med 2004 : 10 : 1041 2.
24. Hamzaoui K, Chelbi H, Kamoun M, Ben Dhifallah I, Hamzaoui A. Increased endothelin-1 levels of BAL fluid in patients with Behçet's disease. Mediators Inflamm 2007 : ID93726 : 1 6.
25. Takagi H, King GL, Ferrara N, Aiello LP. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptor in retinal capillary endothelial cells. Invest Ophthalmol Vis Sci 1996 : 37 : 1311 1321.
26. Lin CC, Wu HC, Tsai FJ, Chen HY, Chen WC. Vascular endothelial growth factor gene -460 C/T polymorphism is a biomarker for prostate cancer. Urology 2003 : 62 : 374 7.
27. Han SW, Kim GW, Seo JS et al. VEGF gene polymorphisms and susceptibility to rheumatoid arthritis. Rheumatology 2004 : 43 : 1173 7.
28. Awata T, Inoue K, Kurihara S et al. A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002 : 51 : 1635 9.
29. Ray D, Mishra M, Ralph S, Read I, Davies R, Brenchley P. Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes 2004 : 53 : 861 4.
30. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000 : 12 : 1232 5.
31. Renner W, Kotschan S, Hoffman C, Obermayer-Pietsch B, Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 2000 : 37 : 443 8.
32. Brogan IJ, Khan N, Isaac K, Hutchinson JA, Pravica V, Hutchinson IV. Novel polymorphisms in the promoter and 5' UTR regions of the human vascular endothelial growth factor gene. Hum Immunol 1999 : 60 : 1245 9.
33. Cooke RWI, Drury JA, Mountford R, Clark D. Genetic polymorphisms and retinopathy of prematurity. Invest Ophthalmol Vis Sci 2004 : 45 : 6.
34. Salvarani C, Boiardi L, Casali B et al. Vascular endothelial growth factor gene polymorphisms in Behcet's disease. J Rheumatol 2004 : 31 : 1785 9.
35. Becit N, Ceviz M, Koçak H et al. The effect of vascular endothelial growth factor on angiogenesis: an experimental study. Eur J Vasc Endovasc Surg 2001 : 22 : 310 6.
36. Er H, Evereklioglu C, Cumurcu T et al. Serum homocysteine level is increased and correlated with endothelin-1 and nitricoxide in Behçet's disease. Br J Ophthalmol 2002 : 86 : 653 7.
37. Evereklioglu C. Current concepts in the etiology and treatment of Behçet disease. Surv Ophthalmol 2005 : 50 : 297 350.
38. Cid MC, Segarra M, Garcia-Martinez A, Hernandez-Rodriguez J. Endothelial cells, antineutrophil cytoplasmic antibodies and cytokines in the pathogenesis of systemic vasculitis. Curr Rheumatol Rep 2004 : 6 : 184 94.
39. Scaria A, Pechan P, Lukason M, Rubin H, Wadsworth S. Inhibition of retinal neovascularization by intraocular gene delivery of soluble VEGF receptors. Mol Ther 2004 : 9 : 198.
40. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997 : 18 : 4.
41. Yang B, Cross DF, Ollerenshaw M, Millward BA, Demaine AG. Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus. J Diabetes Complications 2003 : 17 : 1 6.
42. Erdem F, Gündogdu M, Kiki I, Refik AS, Kiziltunç A. Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet's disease. Rheumatol Int 2005 : 24 : 599 603.
43. Webb NJ, Bottomley MJ, Watson CJ, Brenchley PE. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin Sci (Lond) 1998 : 94 : 395 404.
44. Werther K, Christensen IJ, Nielsen HJ. Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets. Scand J Clin Lab Invest 2002 : 62 : 343 50.
45. Shahbazi M, Fryer AA, Pravica V et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 2002 : 13 : 260 4.
46. Howell WM, Bateman AC, Turner SJ, Collins A, Theaker JM. Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma. Genes Immun 2002 : 3 : 229 32.
47. Boiardi L, Casali B, Nicoli D et al. Vascular endothelial growth factor gene polymorphisms in giant cell arteritis. J Rheumatol 2003 : 30 : 2160 4.